- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03585387
Cardiac Positioning System in Peripheral Angioplasty Procedure. (MDG-Periph)
Fluoroscopy vs Cardiac Positioning System Comparison to Assist the Navigation and Positioning of a Balloon Catheter in a Peripheral Artery During an Angioplasty Procedure
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The present study aims at addressing the fluoroscopy exposure time concern among physicians by proposing a new methodology that capitalizes on the cardiac positioning system (CPS) to reach near-zero fluoroscopy time for interventional cardiologists.
Intracoronary navigation of balloon catheter toward an anatomical landmark will be done with two navigation method:
- Fluoroscopy alone
- Fluoroscopy + CPS combination.
The order of the navigation method (method 1 then method 2 or vice versa) will be determine arbitrarily determined for each subject.
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
Quebec
-
Montréal, Quebec, Canada
- Montreal Heart Institute
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- At least 18 years of age;
- Scheduled for clinically indicated or contemplated percutaneous transluminal angioplasty or stenting of an peripheral artery;
- Able to provide informed consent for study participation and willing and able to comply with the Clinical Investigational Plan described evaluation.
Exclusion Criteria:
- Pregnant women or women planning to be pregnant during the study.
- Patients currently participating in another clinical study
- Patients with a thrombophilia
- Patients with critical limb ischemia
- Patients with unstable clinical condition or conditions limiting life expectancy that, in the opinion of the Study Investigator, excludes the participation.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Kohorter og interventioner
Gruppe / kohorte |
Intervention / Behandling |
---|---|
Main
Each subject in this group will be its own control for the two navigation methods.
|
Navigation of a balloon catheter using two navigation methods (1-Fluoroscopy only; 2- Fluoroscopy + CPS).
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Time of radiation
Tidsramme: Changes from time the balloon leaves the sheath to final alignment with anatomical landmark every 15 minutes over 2 hours.
|
Medical radiation exposure for each balloon positioning
|
Changes from time the balloon leaves the sheath to final alignment with anatomical landmark every 15 minutes over 2 hours.
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
Time duration
Tidsramme: From time the balloon leaves the sheath to final alignment with anatomical landmark every 15 minutes over a 2 hours time frame.
|
Procedure time for each balloon catheter positioning.
|
From time the balloon leaves the sheath to final alignment with anatomical landmark every 15 minutes over a 2 hours time frame.
|
Dose area product (DAP)
Tidsramme: DAP change from when balloon leaves the sheath to final alignment with anatomical landmark assessed every 15 minutes over a 2 hours time frame.
|
Total amount of radiation delivered to the patient
|
DAP change from when balloon leaves the sheath to final alignment with anatomical landmark assessed every 15 minutes over a 2 hours time frame.
|
Success or no-success in balloon navigation
Tidsramme: Determined every 15 minutes over a 2 hours time frame.
|
Physician assessment of balloon navigation and center alignment with an anatomical landmark.
|
Determined every 15 minutes over a 2 hours time frame.
|
Volume of contrast required to get the balloon to the anatomical landmark.
Tidsramme: Change of volume of contrast from when balloon leaves the sheath to final alignment with anatomical landmark assessed every 15 minutes over a 2 hours time frame.
|
Volume used
|
Change of volume of contrast from when balloon leaves the sheath to final alignment with anatomical landmark assessed every 15 minutes over a 2 hours time frame.
|
Distance measurements
Tidsramme: At end of procedure
|
Distance between the center of balloon aligned with anatomical landmark and the two radiopaque balloon markers.
|
At end of procedure
|
Number of adverse events.
Tidsramme: At end of procedure
|
Adverse event count
|
At end of procedure
|
Samarbejdspartnere og efterforskere
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 10252
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Perifer arteriel sygdom
-
Mayo ClinicTilmelding efter invitationAnatomi af GSV for Rescue Peripheral IV AccessForenede Stater
-
Universitaire Ziekenhuizen KU LeuvenUniversity of Pittsburgh; Sheba Medical Center; Mount Sinai Hospital, Canada og andre samarbejdspartnereUkendtTwin Reversal Arterial Perfusion SyndromeSpanien, Tyskland, Israel, Belgien, Holland, Canada, Forenede Stater, Østrig, Frankrig, Italien, Det Forenede Kongerige
-
University of MiamiRekrutteringTvilling til tvilling transfusionssyndrom | Tvilling; Komplicerer graviditet | Twin Reversal Arterial Perfusion Syndrome | Monokorionisk diamniotisk placenta | Monokorial monoamniotisk placentaForenede Stater
-
Boston Children's HospitalIkke rekrutterer endnuGraviditetsrelateret | Moderlige; Procedure | Fostertilstande | Twin Monochorionic Monoamniotic Placenta | Tvilling til tvilling transfusionssyndrom | Twin Reversal Arterial Perfusion Syndrome | Vasa Previa | In utero-procedure, der påvirker foster eller nyfødte | Chorion; Abnorm | ChorioangiomForenede Stater
Kliniske forsøg med Navigation
-
Tongji HospitalGuangdong Provincial People's Hospital; Wuhan Asia Heart Hospital; Fu Wai... og andre samarbejdspartnereUkendtBradykardi | Syg sinus syndrom | Komplet atrioventrikulær blokering | Høj grad anden grad atrioventrikulær blokering (lidelse)Kina
-
Tongji HospitalGuangdong Provincial People's Hospital; Wuhan Asia Heart Hospital; Fu Wai... og andre samarbejdspartnereUkendtBradykardi | Syg sinus syndrom | Høj grad anden grad atrioventrikulær blok | Komplet atrioventrikulær blokeringKina
-
Tufts Medical CenterThe Leukemia and Lymphoma SocietyAktiv, ikke rekrutterendeKræft | Økonomisk stress | OverlevelseForenede Stater
-
Universitätsklinikum Hamburg-EppendorfUkendt
-
StereotaxisAfsluttetVdrive-evaluering af fjernstyring og test i Lasso-elektrofysiologi-procedureundersøgelse (VERSATILE)AtrieflimrenForenede Stater, Belgien, Tyskland
-
Broncus TechnologiesHeidelberg UniversityUkendt
-
University of California, Los AngelesAfsluttetHepatitis C | HIV (Human Immunodeficiency Virus)Forenede Stater
-
University of Illinois at ChicagoRekrutteringSamfundets psykiske sundhedstjenesterForenede Stater
-
University of Colorado, DenverAmerican Cancer Society, Inc.Afsluttet
-
University of California, Los AngelesAfsluttetHIV/AIDSForenede Stater